Generation Bio Co. (GBIO)
NASDAQ: GBIO · Real-Time Price · USD
1.300
-0.050 (-3.70%)
Nov 21, 2024, 10:55 AM EST - Market open
Generation Bio Co. Market Cap
Generation Bio Co. has a market cap or net worth of $86.83 million as of November 21, 2024. Its market cap has increased by 7.95% in one year.
Market Cap
86.83M
Enterprise Value
-15.86M
1-Year Change
7.95%
Ranking
Category
Stock Price
$1.30
Market Cap Chart
Since June 12, 2020, Generation Bio Co.'s market cap has decreased from $1.07B to $86.83M, a decrease of -91.90%. That is a compound annual growth rate of -43.19%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2024 | 90.17M | -17.30% |
| Dec 29, 2023 | 109.03M | -53.31% |
| Dec 30, 2022 | 233.53M | -41.89% |
| Dec 31, 2021 | 401.89M | -68.88% |
| Dec 31, 2020 | 1.29B | 20.54% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Anixa Biosciences | 98.15M |
| Telomir Pharmaceuticals | 98.01M |
| Immunic | 96.38M |
| MultiPlan | 95.90M |
| Allakos | 95.60M |
| FONAR | 95.16M |
| Monopar Therapeutics | 94.88M |
| Quantum-Si incorporated | 94.32M |